Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ILMN

+ Watchlist+ Portfolio

Illumina, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$202.61
52-Week Range
$112.65 – $309.35
Market Cap
$31.75B
P/E (TTM)
36.15
EPS (TTM)
5.81
Dividend Yield
0.00%
Advanced Metrics
Price/Book
10.15
PEG Ratio
2.58
Return on Equity
32.39%
Return on Assets
8.32%
Gross Margin
67.68%
Operating Margin
19.06%
Profit Margin
19.72%
Current Ratio
2.63
Debt/Equity
0.74
Total Debt
$2.31B
Free Cash Flow
$859.00M
Revenue Growth
4.20%
Earnings Growth
45.90%
Enterprise Value
$32.73B

Market Snapshot

About

Illumina, Inc. is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Illumina's sequencing and array-based solutions serve customers in research centers, academic institutions, government laboratories, and hospitals around the world. The company is a dominant player in the next-generation sequencing market and has enabled breakthroughs in genomics research and precision medicine.